Skip to Content

Untreated sleep apnea has economic impact

Untreated sleep apnea has economic impact

The economic burden of undiagnosed obstructive sleep apnea is nearly $150 billion dollars, according to a new study from the American Academy of Sleep Medicine. Those costs include $86.9 billion in lost productivity, $26.2 billion in motor vehicle accidents and $6.5 billion in workplace accidents. Dr. Nathaniel Watson, immediate past president of AASM and a professor of neurology and sleep medicine at the University of Washington, spoke with HME News recently about these “eye-popping” numbers and why there is no downside to addressing the sleep apnea problem.

HME News: This new analysis takes a look at the economic impact of undiagnosed sleep apnea. Why take that view?

Dr. Nathaniel Watson: We live in a time where payers, employers and healthcare entities are looking for cost efficiency. We wanted to demonstrate that taking a proactive, aggressive approach to the diagnosis and management of sleep apnea is a cost-saving measure that can reduce healthcare utilization. There are a couple of numbers that are eye-popping here.

HME: I thought payers were on to the fact that paying for sleep therapy was cost effective?

Watson: Unfortunately, the private payers take a very short-term view of health care and are not necessarily looking at the long-term benefits of prevention. That makes health care more costly then it needs to be. So, for instance, for this analysis, reducing comorbidities was a big cost savings.

HME: Yet CMS has drastically cut reimbursement for sleep therapy.

Watson: I would think of all the healthcare payer entities out there that Medicare would be one that would see the potential to take advantage of the long-term view. There's an opportunity here for Medicare should they choose to embrace it.


To comment on this post, please log in to your account or set up an account now.